Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1146 | 2819 | 30.3 | 84% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
23 | 4 | OPHTHALMOLOGY//OPHTHALMOL//JOURNAL OF CATARACT AND REFRACTIVE SURGERY | 148248 |
242 | 3 | OPHTHALMOLOGY//OPHTHALMOL//AGE RELATED MACULAR DEGENERATION | 47399 |
104 | 2 | OPHTHALMOLOGY//OPHTHALMOL//AGE RELATED MACULAR DEGENERATION | 25595 |
1146 | 1 | RANIBIZUMAB//AGE RELATED MACULAR DEGENERATION//CHOROIDAL NEOVASCULARIZATION | 2819 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | RANIBIZUMAB | authKW | 2323117 | 15% | 51% | 423 |
2 | AGE RELATED MACULAR DEGENERATION | authKW | 1676067 | 25% | 22% | 709 |
3 | CHOROIDAL NEOVASCULARIZATION | authKW | 1022492 | 12% | 29% | 328 |
4 | RETINAL ANGIOMATOUS PROLIFERATION | authKW | 791184 | 3% | 83% | 88 |
5 | AFLIBERCEPT | authKW | 589297 | 4% | 47% | 115 |
6 | INTRAVITREAL INJECTION | authKW | 479061 | 6% | 26% | 170 |
7 | PEGAPTANIB | authKW | 452247 | 2% | 61% | 69 |
8 | ANTI VEGF | authKW | 405383 | 4% | 33% | 112 |
9 | BEVACIZUMAB | authKW | 385772 | 13% | 9% | 376 |
10 | RETINAL PIGMENT EPITHELIAL TEAR | authKW | 306105 | 1% | 91% | 31 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Ophthalmology | 285986 | 85% | 1% | 2393 |
2 | Pharmacology & Pharmacy | 149 | 7% | 0% | 197 |
3 | Medicine, Research & Experimental | 116 | 4% | 0% | 102 |
4 | Medicine, General & Internal | 36 | 4% | 0% | 99 |
5 | Geriatrics & Gerontology | 18 | 1% | 0% | 20 |
6 | Surgery | 7 | 3% | 0% | 94 |
7 | Health Care Sciences & Services | 2 | 1% | 0% | 18 |
8 | Primary Health Care | 1 | 0% | 0% | 4 |
9 | Health Policy & Services | 0 | 0% | 0% | 8 |
10 | Art | -1 | 0% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | OPHTHALMOL | 222305 | 52% | 1% | 1463 |
2 | LUESTHER T MERTZ RETINAL | 96540 | 2% | 20% | 45 |
3 | RETINA SERV | 53748 | 2% | 9% | 53 |
4 | HOSP INTERCOMMUNAL CRETEIL | 46640 | 1% | 17% | 25 |
5 | VITREORETINAL CONSULTANTS | 43321 | 0% | 100% | 4 |
6 | RETINAL DISORDERS OPHTHALM GENET | 36541 | 0% | 38% | 9 |
7 | COLOGNE IMAGE READING | 35439 | 0% | 55% | 6 |
8 | MACULA RETINA | 29474 | 0% | 39% | 7 |
9 | COLE EYE | 29193 | 2% | 5% | 54 |
10 | BARNES RETINA | 24051 | 0% | 22% | 10 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 289384 | 13% | 7% | 363 |
2 | GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 40428 | 5% | 3% | 149 |
3 | OPHTHALMOLOGY | 35906 | 7% | 2% | 190 |
4 | BRITISH JOURNAL OF OPHTHALMOLOGY | 34658 | 6% | 2% | 173 |
5 | AMERICAN JOURNAL OF OPHTHALMOLOGY | 31645 | 6% | 2% | 174 |
6 | OPHTHALMIC SURGERY LASERS & IMAGING RETINA | 24412 | 1% | 6% | 35 |
7 | EYE | 23465 | 4% | 2% | 101 |
8 | EUROPEAN JOURNAL OF OPHTHALMOLOGY | 21172 | 3% | 3% | 71 |
9 | OPHTHALMOLOGE | 19490 | 3% | 3% | 72 |
10 | OPHTHALMOLOGICA | 19203 | 2% | 3% | 68 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RANIBIZUMAB | 2323117 | 15% | 51% | 423 | Search RANIBIZUMAB | Search RANIBIZUMAB |
2 | AGE RELATED MACULAR DEGENERATION | 1676067 | 25% | 22% | 709 | Search AGE+RELATED+MACULAR+DEGENERATION | Search AGE+RELATED+MACULAR+DEGENERATION |
3 | CHOROIDAL NEOVASCULARIZATION | 1022492 | 12% | 29% | 328 | Search CHOROIDAL+NEOVASCULARIZATION | Search CHOROIDAL+NEOVASCULARIZATION |
4 | RETINAL ANGIOMATOUS PROLIFERATION | 791184 | 3% | 83% | 88 | Search RETINAL+ANGIOMATOUS+PROLIFERATION | Search RETINAL+ANGIOMATOUS+PROLIFERATION |
5 | AFLIBERCEPT | 589297 | 4% | 47% | 115 | Search AFLIBERCEPT | Search AFLIBERCEPT |
6 | INTRAVITREAL INJECTION | 479061 | 6% | 26% | 170 | Search INTRAVITREAL+INJECTION | Search INTRAVITREAL+INJECTION |
7 | PEGAPTANIB | 452247 | 2% | 61% | 69 | Search PEGAPTANIB | Search PEGAPTANIB |
8 | ANTI VEGF | 405383 | 4% | 33% | 112 | Search ANTI+VEGF | Search ANTI+VEGF |
9 | BEVACIZUMAB | 385772 | 13% | 9% | 376 | Search BEVACIZUMAB | Search BEVACIZUMAB |
10 | RETINAL PIGMENT EPITHELIAL TEAR | 306105 | 1% | 91% | 31 | Search RETINAL+PIGMENT+EPITHELIAL+TEAR | Search RETINAL+PIGMENT+EPITHELIAL+TEAR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SOLOMON, SD , LINDSLEY, K , VEDULA, SS , KRZYSTOLIK, MG , HAWKINS, BS , (2014) ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 8. P. - | 92 | 78% | 53 |
2 | FRAMPTON, JE , (2013) RANIBIZUMAB: A REVIEW OF ITS USE IN THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.DRUGS & AGING. VOL. 30. ISSUE 5. P. 331-358 | 84 | 88% | 13 |
3 | VAN DER REIS, MI , LA HEIJ, EC , DE JONG-HESSE, Y , RINGENS, PJ , HENDRIKSE, F , SCHOUTEN, JSAG , (2011) A SYSTEMATIC REVIEW OF THE ADVERSE EVENTS OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS.RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES. VOL. 31. ISSUE 8. P. 1449 -1469 | 128 | 54% | 53 |
4 | STEWART, MW , (2014) PHARMACOKINETICS, PHARMACODYNAMICS AND PRE-CLINICAL CHARACTERISTICS OF OPHTHALMIC DRUGS THAT BIND VEGF.EXPERT REVIEW OF CLINICAL PHARMACOLOGY. VOL. 7. ISSUE 2. P. 167 -180 | 90 | 71% | 15 |
5 | ZIEMSSEN, F , GRISANTI, S , BARTZ-SCHMIDT, KU , SPITZER, MS , (2009) OFF-LABEL USE OF BEVACIZUMAB FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION WHAT IS THE EVIDENCE?.DRUGS & AGING. VOL. 26. ISSUE 4. P. 295-320 | 95 | 78% | 17 |
6 | SOLOMON, SD , LINDSLEY, K , VEDULA, SS , KRZYSTOLIK, MG , HAWKINS, BS , (2014) ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 8. P. - | 88 | 77% | 0 |
7 | IP, MS , SCOTT, IU , BROWN, GC , BROWN, MM , HO, AC , HUANG, SS , RECCHIA, FM , (2008) ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR PHARMACOTHERAPY FOR AGE-RELATED MACULAR DEGENERATION.OPHTHALMOLOGY. VOL. 115. ISSUE 10. P. 1837-1846 | 68 | 92% | 95 |
8 | SCHMIDT-ERFURTH, U , CHONG, V , LOEWENSTEIN, A , LARSEN, M , SOUIED, E , SCHLINGEMANN, R , ELDEM, B , MONES, J , RICHARD, G , BANDELLO, F , (2014) GUIDELINES FOR THE MANAGEMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION BY THE EUROPEAN SOCIETY OF RETINA SPECIALISTS (EURETINA).BRITISH JOURNAL OF OPHTHALMOLOGY. VOL. 98. ISSUE 9. P. 1144 -1167 | 80 | 61% | 41 |
9 | JOHNSON, D , SHARMA, S , (2013) OCULAR AND SYSTEMIC SAFETY OF BEVACIZUMAB AND RANIBIZUMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.CURRENT OPINION IN OPHTHALMOLOGY. VOL. 24. ISSUE 3. P. 205-212 | 83 | 78% | 3 |
10 | TOLENTINO, M , (2011) SYSTEMIC AND OCULAR SAFETY OF INTRAVITREAL ANTI-VEGF THERAPIES FOR OCULAR NEOVASCULAR DISEASE.SURVEY OF OPHTHALMOLOGY. VOL. 56. ISSUE 2. P. 95 -113 | 102 | 51% | 90 |
Classes with closest relation at Level 1 |